Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial

Wolfram Doehner, Milton Packer, Stuart Pocock et al.|European Heart Journal|2022

Cited by 122